VS

VCJ Staff

RiverVest Venture Partners Promotes John McKearn to Managing Director

2 min read · 05 May 2011

Chrysalis Ventures Brings Aboard Roy Ziegler as Venture Partner

3 min read · 05 May 2011

RiverVest Venture Partners Promotes John McKearn to Managing Director

RiverVest Venture Partners promoted John McKearn to managing director. McKearn joined RiverVest as a venture partner in 2008. RiverVest is a St. Louis, Mo.-based venture capital firm that invests in emerging medical technology and biopharmaceutical companies

2 min read · 05 May 2011

PowerReviews Raises $10M More In Financing

PowerReviews secured $10 million in financing, bringing its total venture funding to $37 million. The latest round was led by Four Rivers Group, with participation from new investor Woodside Fund and all existing investors, including Menlo Ventures and Tenaya Capital. PowerReviews plans to use the additional funding to extend its product development efforts and expand its sales organization. PowerReviews is a provider of social commerce solutions.

3 min read · 05 May 2011

Jumptap Closes $25 Million Financing Round

Jumptap completed a $25 million financing round. Existing investors AllianceBernstein, General Catalyst, Redpoint Ventures, Summerhill Ventures, Valhalla Partners and WPP, as well as new investors participated in the round. Jumptap plans to use the capital to accelerate its growth through product and technology development, and added staffing to support increasing client demand. Jumptap is a Cambridge, Mass.-based company involved in targeted mobile advertising.

3 min read · 05 May 2011

Mashery Raises $11 Million

Mashery has raised $11 million in funding. OpenView Venture Partners led the round that had participation from existing investors: Cisco, Formative Ventures, First Round Capital and .406 Ventures. Mashery plans to use the financing to broaden its current offering and to expand its sales and marketing activities. Mashery is a San Francisco, Calif.-based provider of Application Programming Interface management tools and services.

3 min read · 05 May 2011

Newtopia Gets Seed Funding From BDC Venture Capital

Newtopia Inc. received seed funding from the Business Development Bank of Canada, which made the investment through its Venture Capital division. The financing was completed in partnership with a group of Canadian angel investors, including Newtopia Chairman and Co-founder Dennis Bennie. Newpotia is a personalized health coaching company.

3 min read · 05 May 2011

BioAmber Closes $45 Million Series B Financing Round

BioAmber Inc. has raised $45 million in a Series B financing. . The round was led by NAXOS Capital Partners, a European based growth capital fund. Mitsui & Co. Venture Partners, a new investor, participated in the round, which was co-led by Sofinnova Partners. Cliffton Group of Montreal, Quebec, also participated. BioAmber is a Minneapolis, Minn.-based renewable chemistry company. It plans to use the financing to accelerate the commercialization of succinic acid and modified PBS, a biodegradable plastic offering better heat resistance and processability than other biopolymers.

3 min read · 04 May 2011

PlumChoice Raises $25.6 Million

PlumChoice has raised $25.6 million in financing to meet the growing market demand and expansion requirements for its premium Technology Care services. PlumChoice is a Billerica, Mass.-based provider of remote technology support services to the home and small business markets. It plans to use proceeds to fund growth, expand sales and marketing, and enhance the breadth of its platform services. M/C Venture Partners, Gold Hill Capital and Eastward Capital participated in the financing.

3 min read · 04 May 2011

Crown Bioscience Closes $28.8M Series C Financing Round

Crown Bioscience Inc. closed a Series C financing round at $28.8 million. OrbiMed Advisors Caduceus Asia Partners Fund, Argonaut Private Equity, the CID Group, IBT and CDIB Capital Investment led the round. Existing shareholders Qiming Venture Partners and CRCI also participated.Crown Bioscience plans to use proceeds to expand services in integrated cancer drug discovery and translational oncology, as well as to fund new initiatives in other therapeutic areas. Crown Bioscience is a Santa Clara, Calif.-based company involved in oncology research and development partnership and services.

5 min read · 04 May 2011

Showing 3,531 to 3,540 of 12,105 results
1…353355…1000